Detail Information of Post-Translational Modifications

General Information of Drug Transporter (DT)
DT ID	DTD0529 Transporter Info
Gene Name	SCN9A
Transporter Name	Voltage-gated sodium channel alpha Nav1.7
Gene ID	6335
UniProt ID	Q15858

Post-Translational Modification of This DT
Overview of SCN9A Modification Sites with Functional and Structural Information
Sequence	M A M L P P P G P Q S F V H F T K Q S L A L I E Q R I A E R K S K E P K E E K K D D D E E A P K P S S D L E A G K Q L P F I Y G D I P P G M V S E P L E D L D P Y Y A D K K T F I V L N K G K T I F R F N A T P A L Y M L S P F S P L R R I S I K I L V H S L F S M L I M C T I L T N C I F M T M N N P P D W T K N V E Y T F T G I Y T F E S L V K I L A R G F C V G E F T F L R D P W N W L D F V V I V F A Y L T E F V N L G N V S A L R T F R V L R A L K T I S V I P G L K T I V G A L I Q S V K K L S D V M I L T V F C L S V F A L I G L Q L F M G N L K H K C F R N S L E N N E T L E S I M N T L E S E E D F R K Y F Y Y L E G S K D A L L C G F S T D S G Q C P E G Y T C V K I G R N P D Y G Y T S F D T F S W A F L A L F R L M T Q D Y W E N L Y Q Q T L R A A G K T Y M I F F V V V I F L G S F Y L I N L I L A V V A M A Y E E Q N Q A N I E E A K Q K E L E F Q Q M L D R L K K E Q E E A E A I A A A A A E Y T S I R R S R I M G L S E S S S E T S K L S S K S A K E R R N R R K K K N Q K K L S S G E E K G D A E K L S K S E S E D S I R R K S F H L G V E G H R R A H E K R L S T P N Q S P L S I R G S L F S A R R S S R T S L F S F K G R G R D I G S E T E F A D D E H S I F G D N E S R R G S L F V P H R P Q E R R S S N I S Q A S R S P P M L P V N G K M H S A V D C N G V V S L V D G R S A L M L P N G Q L L P E V I I D K A T S D D S G T T N Q I H K K R R C S S Y L L S E D M L N D P N L R Q R A M S R A S I L T N T V E E L E E S R Q K C P P W W Y R F A H K F L I W N C S P Y W I K F K K C I Y F I V M D P F V D L A I T I C I V L N T L F M A M E H H P M T E E F K N V L A I G N L V F T G I F A A E M V L K L I A M D P Y E Y F Q V G W N I F D S L I V T L S L V E L F L A D V E G L S V L R S F R L L R V F K L A K S W P T L N M L I K I I G N S V G A L G N L T L V L A I I V F I F A V V G M Q L F G K S Y K E C V C K I N D D C T L P R W H M N D F F H S F L I V F R V L C G E W I E T M W D C M E V A G Q A M C L I V Y M M V M V I G N L V V L N L F L A L L L S S F S S D N L T A I E E D P D A N N L Q I A V T R I K K G I N Y V K Q T L R E F I L K A F S K K P K I S R E I R Q A E D L N T K K E N Y I S N H T L A E M S K G H N F L K E K D K I S G F G S S V D K H L M E D S D G Q S F I H N P S L T V T V P I A P G E S D L E N M N A E E L S S D S D S E Y S K V R L N R S S S S E C S T V D N P L P G E G E E A E A E P M N S D E P E A C F T D G C V W R F S C C Q V N I E S G K G K I W W N I R K T C Y K I V E H S W F E S F I V L M I L L S S G A L A F E D I Y I E R K K T I K I I L E Y A D K I F T Y I F I L E M L L K W I A Y G Y K T Y F T N A W C W L D F L I V D V S L V T L V A N T L G Y S D L G P I K S L R T L R A L R P L R A L S R F E G M R V V V N A L I G A I P S I M N V L L V C L I F W L I F S I M G V N L F A G K F Y E C I N T T D G S R F P A S Q V P N R S E C F A L M N V S Q N V R W K N L K V N F D N V G L G Y L S L L Q V A T F K G W T I I M Y A A V D S V N V D K Q P K Y E Y S L Y M Y I Y F V V F I I F G S F F T L N L F I G V I I D N F N Q Q K K K L G G Q D I F M T E E Q K K Y Y N A M K K L G S K K P Q K P I P R P G N K I Q G C I F D L V T N Q A F D I S I M V L I C L N M V T M M V E K E G Q S Q H M T E V L Y W I N V V F I I L F T G E C V L K L I S L R H Y Y F T V G W N I F D F V V V I I S I V G M F L A D L I E T Y F V S P T L F R V I R L A R I G R I L R L V K G A K G I R T L L F A L M M S L P A L F N I G L L L F L V M F I Y A I F G M S N F A Y V K K E D G I N D M F N F E T F G N S M I C L F Q I T T S A G W D G L L A P I L N S K P P D C D P K K V H P G S S V E G D C G N P S V G I F Y F V S Y I I I S F L V V V N M Y I A V I L E N F S V A T E E S T E P L S E D D F E M F Y E V W E K F D P D A T Q F I E F S K L S D F A A A L D P P L L I A K P N K V Q L I A M D L P M V S G D R I H C L D I L F A F T K R V L G E S G E M D S L R S Q M E E R F M S A N P S K V S Y E P I T T T L K R K Q E D V S A T V I Q R A Y R R Y R L R Q N V K N I S S I Y I K D G D R D D D L L N K K D M A F D N V N E N S S P E K T D A T S S T T S P P S Y D S V T K P D K E K Y E Q D R T E K E D K G K D S K E S K K
PTM type	X-Acetylation X-N-glycosylation X-Oxidation X-Phosphorylation X-Ubiquitination X: Amino Acid

Acetylation
Lysine	5 PTM Phenomena Related to This Residue		Click to Show/Hide the Full List
PTM Phenomenon 1	Have the potential to influence SCN9A			[1]
Role of PTM	Potential impacts
Modified Residue	Lysine	Modified Location	483
Experimental Method	Co-Immunoprecipitation
Detailed Description	Acetylation at SCN9A Lysine 483 has the potential to affect its expression or activity.
PTM Phenomenon 2	Have the potential to influence SCN9A			[2]
Role of PTM	Potential impacts
Modified Residue	Lysine	Modified Location	494
Experimental Method	Co-Immunoprecipitation
Detailed Description	Acetylation at SCN9A Lysine 494 has the potential to affect its expression or activity.
PTM Phenomenon 3	Have the potential to influence SCN9A			[3]
Role of PTM	Potential impacts
Modified Residue	Lysine	Modified Location	1034
Experimental Method	Co-Immunoprecipitation
Detailed Description	Acetylation at SCN9A Lysine 1034 has the potential to affect its expression or activity.
PTM Phenomenon 4	Have the potential to influence SCN9A			[4]
Role of PTM	Potential impacts
Modified Residue	Lysine	Modified Location	1480
Experimental Method	Co-Immunoprecipitation
Detailed Description	Acetylation at SCN9A Lysine 1480 has the potential to affect its expression or activity.
PTM Phenomenon 5	Have the potential to influence SCN9A			[5]
Role of PTM	Potential impacts
Modified Residue	Lysine	Modified Location	1981
Experimental Method	Co-Immunoprecipitation
Detailed Description	Acetylation at SCN9A Lysine 1981 has the potential to affect its expression or activity.
N-glycosylation
Asparagine	6 PTM Phenomena Related to This Residue		Click to Show/Hide the Full List
PTM Phenomenon 1	Have the potential to influence SCN9A			[6]
Role of PTM	Potential impacts
Modified Residue	Asparagine	Modified Location	209
Experimental Method	Co-Immunoprecipitation
Detailed Description	N-linked Glycosylation at SCN9A Asparagine 209 has the potential to affect its expression or activity.
PTM Phenomenon 2	Have the potential to influence SCN9A			[7]
Role of PTM	Potential impacts
Modified Residue	Asparagine	Modified Location	283
Experimental Method	Co-Immunoprecipitation
Detailed Description	N-linked Glycosylation at SCN9A Asparagine 283 has the potential to affect its expression or activity.
PTM Phenomenon 3	Have the potential to influence SCN9A			[7]
Role of PTM	Potential impacts
Modified Residue	Asparagine	Modified Location	1341
Experimental Method	Co-Immunoprecipitation
Detailed Description	N-linked Glycosylation at SCN9A Asparagine 1341 has the potential to affect its expression or activity.
PTM Phenomenon 4	Have the potential to influence SCN9A			[7]
Role of PTM	Potential impacts
Modified Residue	Asparagine	Modified Location	1352
Experimental Method	Co-Immunoprecipitation
Detailed Description	N-linked Glycosylation at SCN9A Asparagine 1352 has the potential to affect its expression or activity.
PTM Phenomenon 5	Have the potential to influence SCN9A			[7]
Role of PTM	Potential impacts
Modified Residue	Asparagine	Modified Location	1366
Experimental Method	Co-Immunoprecipitation
Detailed Description	N-linked Glycosylation at SCN9A Asparagine 1366 has the potential to affect its expression or activity.
PTM Phenomenon 6	Have the potential to influence SCN9A			[7]
Role of PTM	Potential impacts
Modified Residue	Asparagine	Modified Location	1375
Experimental Method	Co-Immunoprecipitation
Detailed Description	N-linked Glycosylation at SCN9A Asparagine 1375 has the potential to affect its expression or activity.
Asparticacid	1 PTM Phenomena Related to This Residue		Click to Show/Hide the Full List
PTM Phenomenon 1	Have the potential to influence SCN9A			[7]
Role of PTM	Potential impacts
Modified Residue	Asparticacid	Modified Location	1355
Experimental Method	Co-Immunoprecipitation
Detailed Description	N-linked Glycosylation at SCN9A Asparticacid 1355 has the potential to affect its expression or activity.
Valine	1 PTM Phenomena Related to This Residue		Click to Show/Hide the Full List
PTM Phenomenon 1	Have the potential to influence SCN9A			[7]
Role of PTM	Potential impacts
Modified Residue	Valine	Modified Location	1364
Experimental Method	Co-Immunoprecipitation
Detailed Description	N-linked Glycosylation at SCN9A Valine 1364 has the potential to affect its expression or activity.
Oxidation
Cystine	1 PTM Phenomena Related to This Residue		Click to Show/Hide the Full List
PTM Phenomenon 1	Have the potential to influence SCN9A			[8]
Role of PTM	Potential impacts
Modified Residue	Cystine	Modified Location	624
Experimental Method	Co-Immunoprecipitation
Detailed Description	Oxidation at SCN9A Cystine 624 has the potential to affect its expression or activity.
Phosphorylation
Alanine	1 PTM Phenomena Related to This Residue		Click to Show/Hide the Full List
PTM Phenomenon 1	Have the potential to influence SCN9A			[9]
Role of PTM	Potential impacts
Modified Residue	Alanine	Modified Location	1153
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SCN9A Alanine 1153 has the potential to affect its expression or activity.
Glycine	1 PTM Phenomena Related to This Residue		Click to Show/Hide the Full List
PTM Phenomenon 1	Have the potential to influence SCN9A			[10]
Role of PTM	Potential impacts
Modified Residue	Glycine	Modified Location	1407
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SCN9A Glycine 1407 has the potential to affect its expression or activity.
Lysine	1 PTM Phenomena Related to This Residue		Click to Show/Hide the Full List
PTM Phenomenon 1	Have the potential to influence SCN9A			[11]
Role of PTM	Potential impacts
Modified Residue	Lysine	Modified Location	1479
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SCN9A Lysine 1479 has the potential to affect its expression or activity.
Serine	25 PTM Phenomena Related to This Residue		Click to Show/Hide the Full List
PTM Phenomenon 1	Increasing the peak sodium currents of SCN9A			[11]
Role of PTM	Protein Activity Modulation
Modified Residue	Serine	Modified Location	1490
Related Enzyme	Protein kinase C alpha type (PRKCA)
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SCN9A Serine 1490 have been reported to increase its peak sodium currents.
PTM Phenomenon 2	Have the potential to influence SCN9A			[12]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	113
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SCN9A Serine 113 has the potential to affect its expression or activity.
PTM Phenomenon 3	Have the potential to influence SCN9A			[13]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	469
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SCN9A Serine 469 has the potential to affect its expression or activity.
PTM Phenomenon 4	Have the potential to influence SCN9A			[13]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	470
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SCN9A Serine 470 has the potential to affect its expression or activity.
PTM Phenomenon 5	Have the potential to influence SCN9A			[13]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	472
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SCN9A Serine 472 has the potential to affect its expression or activity.
PTM Phenomenon 6	Have the potential to influence SCN9A			[12] , [14]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	530
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SCN9A Serine 530 has the potential to affect its expression or activity.
PTM Phenomenon 7	Have the potential to influence SCN9A			[14] , [15]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	535
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SCN9A Serine 535 has the potential to affect its expression or activity.
PTM Phenomenon 8	Have the potential to influence SCN9A			[15] , [16]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	538
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SCN9A Serine 538 has the potential to affect its expression or activity.
PTM Phenomenon 9	Have the potential to influence SCN9A			[9]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	545
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SCN9A Serine 545 has the potential to affect its expression or activity.
PTM Phenomenon 10	Have the potential to influence SCN9A			[9]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	549
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SCN9A Serine 549 has the potential to affect its expression or activity.
PTM Phenomenon 11	Have the potential to influence SCN9A			[17]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	550
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SCN9A Serine 550 has the potential to affect its expression or activity.
PTM Phenomenon 12	Have the potential to influence SCN9A			[9] , [18]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	556
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SCN9A Serine 556 has the potential to affect its expression or activity.
PTM Phenomenon 13	Have the potential to influence SCN9A			[18]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	566
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SCN9A Serine 566 has the potential to affect its expression or activity.
PTM Phenomenon 14	Have the potential to influence SCN9A			[19]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	600
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SCN9A Serine 600 has the potential to affect its expression or activity.
PTM Phenomenon 15	Have the potential to influence SCN9A			[15] , [20]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	694
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SCN9A Serine 694 has the potential to affect its expression or activity.
PTM Phenomenon 16	Have the potential to influence SCN9A			[9]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	832
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SCN9A Serine 832 has the potential to affect its expression or activity.
PTM Phenomenon 17	Have the potential to influence SCN9A			[21]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	1039
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SCN9A Serine 1039 has the potential to affect its expression or activity.
PTM Phenomenon 18	Have the potential to influence SCN9A			[21]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	1047
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SCN9A Serine 1047 has the potential to affect its expression or activity.
PTM Phenomenon 19	Have the potential to influence SCN9A			[9] , [18]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	1164
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SCN9A Serine 1164 has the potential to affect its expression or activity.
PTM Phenomenon 20	Have the potential to influence SCN9A			[10] , [22]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	1418
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SCN9A Serine 1418 has the potential to affect its expression or activity.
PTM Phenomenon 21	Have the potential to influence SCN9A			[23]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	1605
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SCN9A Serine 1605 has the potential to affect its expression or activity.
PTM Phenomenon 22	Have the potential to influence SCN9A			[24]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	1869
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SCN9A Serine 1869 has the potential to affect its expression or activity.
PTM Phenomenon 23	Have the potential to influence SCN9A			[24]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	1873
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SCN9A Serine 1873 has the potential to affect its expression or activity.
PTM Phenomenon 24	Have the potential to influence SCN9A			[25]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	1941
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SCN9A Serine 1941 has the potential to affect its expression or activity.
PTM Phenomenon 25	Have the potential to influence SCN9A			[26]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	1960
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SCN9A Serine 1960 has the potential to affect its expression or activity.
Threonine	9 PTM Phenomena Related to This Residue		Click to Show/Hide the Full List
PTM Phenomenon 1	Have the potential to influence SCN9A			[12]
Role of PTM	Potential impacts
Modified Residue	Threonine	Modified Location	103
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SCN9A Threonine 103 has the potential to affect its expression or activity.
PTM Phenomenon 2	Have the potential to influence SCN9A			[13]
Role of PTM	Potential impacts
Modified Residue	Threonine	Modified Location	285
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SCN9A Threonine 285 has the potential to affect its expression or activity.
PTM Phenomenon 3	Have the potential to influence SCN9A			[16] , [18]
Role of PTM	Potential impacts
Modified Residue	Threonine	Modified Location	531
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SCN9A Threonine 531 has the potential to affect its expression or activity.
PTM Phenomenon 4	Have the potential to influence SCN9A			[15] , [20]
Role of PTM	Potential impacts
Modified Residue	Threonine	Modified Location	697
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SCN9A Threonine 697 has the potential to affect its expression or activity.
PTM Phenomenon 5	Have the potential to influence SCN9A			[15] , [20]
Role of PTM	Potential impacts
Modified Residue	Threonine	Modified Location	699
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SCN9A Threonine 699 has the potential to affect its expression or activity.
PTM Phenomenon 6	Have the potential to influence SCN9A			[21]
Role of PTM	Potential impacts
Modified Residue	Threonine	Modified Location	1042
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SCN9A Threonine 1042 has the potential to affect its expression or activity.
PTM Phenomenon 7	Have the potential to influence SCN9A			[23]
Role of PTM	Potential impacts
Modified Residue	Threonine	Modified Location	1607
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SCN9A Threonine 1607 has the potential to affect its expression or activity.
PTM Phenomenon 8	Have the potential to influence SCN9A			[27]
Role of PTM	Potential impacts
Modified Residue	Threonine	Modified Location	1949
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SCN9A Threonine 1949 has the potential to affect its expression or activity.
PTM Phenomenon 9	Have the potential to influence SCN9A			[25]
Role of PTM	Potential impacts
Modified Residue	Threonine	Modified Location	1953
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SCN9A Threonine 1953 has the potential to affect its expression or activity.
Tyrosine	6 PTM Phenomena Related to This Residue		Click to Show/Hide the Full List
PTM Phenomenon 1	Have the potential to influence SCN9A			[12]
Role of PTM	Potential impacts
Modified Residue	Tyrosine	Modified Location	107
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SCN9A Tyrosine 107 has the potential to affect its expression or activity.
PTM Phenomenon 2	Have the potential to influence SCN9A			[21]
Role of PTM	Potential impacts
Modified Residue	Tyrosine	Modified Location	1037
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SCN9A Tyrosine 1037 has the potential to affect its expression or activity.
PTM Phenomenon 3	Have the potential to influence SCN9A			[10] , [22]
Role of PTM	Potential impacts
Modified Residue	Tyrosine	Modified Location	1413
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SCN9A Tyrosine 1413 has the potential to affect its expression or activity.
PTM Phenomenon 4	Have the potential to influence SCN9A			[28] , [29]
Role of PTM	Potential impacts
Modified Residue	Tyrosine	Modified Location	1481
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SCN9A Tyrosine 1481 has the potential to affect its expression or activity.
PTM Phenomenon 5	Have the potential to influence SCN9A			[28] , [30]
Role of PTM	Potential impacts
Modified Residue	Tyrosine	Modified Location	1482
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SCN9A Tyrosine 1482 has the potential to affect its expression or activity.
PTM Phenomenon 6	Have the potential to influence SCN9A			[31]
Role of PTM	Potential impacts
Modified Residue	Tyrosine	Modified Location	1877
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SCN9A Tyrosine 1877 has the potential to affect its expression or activity.
Valine	1 PTM Phenomena Related to This Residue		Click to Show/Hide the Full List
PTM Phenomenon 1	Have the potential to influence SCN9A			[10]
Role of PTM	Potential impacts
Modified Residue	Valine	Modified Location	1402
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SCN9A Valine 1402 has the potential to affect its expression or activity.
Ubiquitination
Glycine	1 PTM Phenomena Related to This Residue		Click to Show/Hide the Full List
PTM Phenomenon 1	Have the potential to influence SCN9A			[32]
Role of PTM	Potential impacts
Modified Residue	Glycine	Modified Location	94
Experimental Method	Co-Immunoprecipitation
Detailed Description	Ubiquitination at SCN9A Glycine 94 has the potential to affect its expression or activity.
Lysine	1 PTM Phenomena Related to This Residue		Click to Show/Hide the Full List
PTM Phenomenon 1	Have the potential to influence SCN9A			[32]
Role of PTM	Potential impacts
Modified Residue	Lysine	Modified Location	223
Experimental Method	Co-Immunoprecipitation
Detailed Description	Ubiquitination at SCN9A Lysine 223 has the potential to affect its expression or activity.

References
1	A new nonabsorbable adhesion barrier for myomectomy. Am J Surg. 2002 Nov;184(5):428-32.
2	Expression of gamma-amino butyric acid and its receptor in the marginal division of rat striatum. Di Yi Jun Yi Da Xue Xue Bao. 2002 Nov;22(11):961-5.
3	Are traditional Chinese medicine theories of normal delivery supported by evidence-based medicine?. Midwifery Today Int Midwife. 2009 Autumn;(91):32-3.
4	Optimising age adjustment of trichiasis prevalence estimates using data from 162 standardised surveys from seven regions of Ethiopia. Ophthalmic Epidemiol. 2019 Jun;26(3):161-168.
5	TNF-alpha receptor expression correlates with histologic activity of otosclerosis. Otol Neurotol. 2009 Dec;30(8):1131-7.
6	dbPTM in 2022: an updated database for exploring regulatory networks and functional associations of protein post-translational modifications. Nucleic Acids Res. 2022 Jan 7;50(D1):D471-D479. (ID: SCN9A_HUMAN)
7	Structures of human Na(v)1.7 channel in complex with auxiliary subunits and animal toxins. Science. 2019 Mar 22;363(6433):1303-1308.
8	A Quantitative Tissue-Specific Landscape of Protein Redox Regulation during Aging. Cell. 2020 Mar 5;180(5):968-983.e24.
9	Ischemia in tumors induces early and sustained phosphorylation changes in stress kinase pathways but does not affect global protein levels. Mol Cell Proteomics. 2014 Jul;13(7):1690-704.
10	Improved titanium dioxide enrichment of phosphopeptides from HeLa cells and high confident phosphopeptide identification by cross-validation of MS/MS and MS/MS/MS spectra. J Proteome Res. 2007 Nov;6(11):4150-62.
11	Protein kinase C enhances human sodium channel hNav1.7 resurgent currents via a serine residue in the domain III-IV linker. FEBS Lett. 2014 Nov 3;588(21):3964-9.
12	Global phosphoproteome analysis of human bone marrow reveals predictive phosphorylation markers for the treatment of acute myeloid leukemia with quizartinib. Leukemia. 2014 Mar;28(3):716-9.
13	A fast sample processing strategy for large-scale profiling of human urine phosphoproteome by mass spectrometry. Talanta. 2018 Aug 1;185:166-173.
14	Quantitative phosphoproteomic analysis of acquired cancer drug resistance to pazopanib and dasatinib. J Proteomics. 2018 Jan 6;170:130-140.
15	Phosphoproteomics reveals ALK promote cell progress via RAS/ JNK pathway in neuroblastoma. Oncotarget. 2016 Nov 15;7(46):75968-75980.
16	Identification of missing proteins in the neXtProt database and unregistered phosphopeptides in the PhosphoSitePlus database as part of the Chromosome-centric Human Proteome Project. J Proteome Res. 2013 Jun 7;12(6):2414-21.
17	Phosphosignature predicts dasatinib response in non-small cell lung cancer. Mol Cell Proteomics. 2012 Sep;11(9):651-68.
18	Phosphoproteome dynamics in onset and maintenance of oncogene-induced senescence. Mol Cell Proteomics. 2014 Aug;13(8):2089-100.
19	Actionable Cytopathogenic Host Responses of Human Alveolar Type 2 Cells to SARS-CoV-2. Mol Cell. 2020 Dec 17;80(6):1104-1122.e9.
20	Triomics Analysis of Imatinib-Treated Myeloma Cells Connects Kinase Inhibition to RNA Processing and Decreased Lipid Biosynthesis. Anal Chem. 2015 Nov 3;87(21):10995-1006.
21	An integrated strategy for highly sensitive phosphoproteome analysis from low micrograms of protein samples. Analyst. 2018 Jul 23;143(15):3693-3701.
22	Chronic exposure to cigarette smoke leads to activation of p21 (RAC1)-activated kinase 6 (PAK6) in non-small cell lung cancer cells. Oncotarget. 2016 Sep 20;7(38):61229-61245.
23	Proteogenomic integration reveals therapeutic targets in breast cancer xenografts. Nat Commun. 2017 Mar 28;8:14864.
24	Targeting CDK2 overcomes melanoma resistance against BRAF and Hsp90 inhibitors. Mol Syst Biol. 2018 Mar 5;14(3):e7858.
25	Robust, Reproducible, and Economical Phosphopeptide Enrichment Using Calcium Titanate. J Proteome Res. 2019 Mar 1;18(3):1411-1417.
26	Global phosphoproteomic analysis reveals ARMC10 as an AMPK substrate that regulates mitochondrial dynamics. Nat Commun. 2019 Jan 10;10(1):104.
27	iTRAQ labeling is superior to mTRAQ for quantitative global proteomics and phosphoproteomics. Mol Cell Proteomics. 2012 Jun;11(6):M111.014423.
28	Systematic functional prioritization of protein posttranslational modifications. Cell. 2012 Jul 20;150(2):413-25.
29	Phosphoproteomics Analysis Identifies Novel Candidate Substrates of the Nonreceptor Tyrosine Kinase, S rc- r elated Kinase Lacking C-terminal Regulatory Tyrosine and N-terminal M yristoylation S ites (SRMS). Mol Cell Proteomics. 2018 May;17(5):925-947.
30	Modulation of the cardiac sodium channel NaV1.5 by Fyn, a Src family tyrosine kinase. Circ Res. 2005 May 13;96(9):991-8.
31	Neuroblastoma tyrosine kinase signaling networks involve FYN and LYN in endosomes and lipid rafts. PLoS Comput Biol. 2015 Apr 17;11(4):e1004130.
32	Highly Multiplexed Quantitative Mass Spectrometry Analysis of Ubiquitylomes. Cell Syst. 2016 Oct 26;3(4):395-403.e4.

If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.

Detail Information of Post-Translational Modifications

Visitor Map

Correspondence